Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Science
Tobi Thomas

Weight-loss drugs under review in UK after reports of suicidal thoughts

A box of Ozempic being picked up at a pharmacy
Ozempic was originally approved to treat type 2 diabetes but has gained enormous popularity for facilitating weight loss. Photograph: George Frey/Reuters

A popular weight-loss drug is among those being reviewed in the UK after being linked to reports of suicidal or self-harming thoughts within patients.

Reuters reports that the Medicines and Healthcare Products Regulatory Agency (MHRA) said in the statement that it was reviewing a class of drugs known as GLP-1 receptor agonists, sold by the company Novo Nordisk.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.